Last edition
News about
Orchard Therapeutics, a global gene therapy leader, and Pharming Group NV, a global and commercial stage biopharmaceutical company, have jointly announced a strategic collaboration to research, develop, manufacture and commercialize OTL-105
Molbio Diagnostics, one of India's leading healthcare companies in the in-vitro diagnostics segment, launched a new manufacturing unit for its innovative molecular diagnostic platform - Truenat Real-Time PCR, spread across 1,35,000 Sq.ft, in Verna, Goa.
Alembic Pharma receives US FDA approval for generic Macrodantin capsules
Alembic Pharmaceuticals Limited announced that it has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for nitrofurantoin capsules, USP (Macrocrystals), 25 mg, 50 mg and 100 mg
Optima announces new laboratory, scheduling and resource management system
Optima's algorithm combines all information collected in the system setting and the historical data generated, to provide a scheduling proposal on the best way to coordinate the human and instruments resources to execute the tasks requested and respond to the laboratory's demand.
Management of patient's recovery from effects of COVID 19 is the key focus point to going back to normalcy. To help the patient recover faster, Mumbai based Pharma, Healthcare & Nutraceutical supplement maker Adroit Biomed Limited today launched its immunity enhancing tablets Glutone MD
ATAL Faculty Development Programme deliberate on novel ideas in drug design and engineering
The programme was jointly organized by Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR) and Delhi Pharmaceutical Sciences and Research University (DPSRU) in which lectures were delivered by prominent scientists from around the country in the field of pharmaceutical sciences
Dr. Reddy's Labs announces commercial launch of 2-DG
Dr Reddy's will supply to major government as well as private hospitals across India. In the initial weeks, the company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India
Biomerica inks pact with Canadian partner to distribute & market Helicobacter pylori test, hp+detect
Biomerica announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the distribution and marketing of Biomerica's new and proprietary Helicobacter pylori test, called hp+detect
Ipca Laboratories Ltd has received approval from the subject expert committee (SEC) at Central Drugs Standard Control Organisation (CDSCO) to conduct phase III study of antimalarial drug hydroxychloroquine (HCQ) as an add-on therapy in type 2 diabetes patients uncontrolled on metformin monotherapy
Centrient Pharmaceuticals boosting statins API manufacturing capacity
Centrient Pharmaceuticals today announced to have started production at its new statins manufacturing unit. With the building of its second dedicated unit on the Toansa site in India now completed. The company will double its statins production capacity that will enable it to meet the growing demand for its sustainably manufactured Atorvastatin
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy